To learn about Rational Vaccines Genital Herpes Clinical Trial, click here.

X
logo
  • Our team
  • Our science
  • About herpes
  • Resources
  • In the News
Rational Vaccines
  • Our team
  • Our science
  • About herpes
  • Resources
  • In the News
This website uses cookies to improve your experience and analyze site traffic. You can read more about our cookie and privacy policy by here.
Accept

Author: rvacdev

  • August 18, 2022
    Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus
  • July 9, 2022
    Rationals Experimental Herpes Vaccine Shows Preclinical Promise
  • July 8, 2022
    Rational’s Experimental Herpes Vaccine Shows Preclinical Promise
  • June 10, 2022
    2022 BIO International Convention
  • June 10, 2022
    The Major Breakthrough That Completely Stopped This Woman’s Painful Genital Herpes Outbreaks
  • January 3, 2022
    Biotech Showcase
  • December 14, 2021
    RVx201 Herpes Vaccine — Precision Vaccinations
  • November 16, 2021
    Jeffries London Healthcare Conference
  • July 26, 2021
    A Rationally Designed Therapeutic Vaccine for Herpes
  • April 10, 2021
    Meet Rational’s Dr. Gus Kousoulas
  • Posts navigation

    Older posts
logo
  • Our team
  • Our science
  • About herpes
  • Resources

Location
Rational Vaccines, Inc.
8 Cabot Rd #3800, Woburn, MA 01801, USA
(781) 305-3600

Contact
Patient Advocate: Diane Abbitt, patientadvocate@abbittlaw.com
For media inquiries please contact Rational@luckybreakpr.com

Privacy Policy Terms of Use

© 2023 Rational Vaccines. RATIONAL VACCINES, IT’S TIME TO FACE HERPES and related logos are trademarks of Rational Vaccines, Inc.